Effect of Lithium Versus Placebo in Adults With Treatment-Resistant Depression Who Are Receiving Ketamine

Summary

The purpose of this research study is to compare the antidepressant effect of lithium versus placebo in adults receiving ketamine. Lithium is available commercially for depression; ketamine is available commercially and can help the symptoms of depression; however, it has not been approved by the U.S. Food and Drug Administration (FDA) for this use. The FDA has allowed the use of this drug in this research study.

Timeline

Start

2017-11-30

Primary completion

2018-12

Completion

2018-12

Outcome

Outcome not reported

Stopped: “Principal Investigator moved to Jacksonville, FL campus.”

Drugs

Indications

No indication recorded.